Filing Details
- Accession Number:
- 0001127602-13-020319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-13 16:27:05
- Reporting Period:
- 2013-06-11
- Filing Date:
- 2013-06-13
- Accepted Time:
- 2013-06-13 16:27:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202098 | Stelios Papadopoulos | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-06-11 | 2,020 | $219.62 | 12,930 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-06-12 | 1,305 | $0.00 | 14,235 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | A | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.